Pricing is the most important profit lever for any business, but it is too often an afterthought in most new product launches, resulting in sub-optimal monetization. By integrating key pricing activities from R&D through launch, companies can ensure that they maximize the value of their assets. We will highlight a step-wise approach to pricing that has been used successfully at start-ups as well as large life science companies.
About the Speaker
David Lee is a Partner in the San Francisco office of Simon-Kucher & Partners where he advises life science clients on optimal pricing, marketing, sales, and negotiation strategies. He has over 15 years of experience in healthcare and consulting, specializing in medical technologies, diagnostics, healthcare IT, and digital health. Prior to joining Simon-Kucher & Partners, David worked in sales and marketing operating roles at Johnson & Johnson, Boston Scientific, and AccessClosure, Inc (acquired by Cardinal Health). David received his MBA from the MIT Sloan School of Management and graduated from the University of California at Berkeley, with a BA in Latin Language.